journal article·2024-01-28Open access

Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives

Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, Reka Barabas, Bianca Adina Boşca, Alexandrina Muntean, Dana Feștilă, Aranka Ilea

Abstract

This review aimed at searching literature for data regarding the inflammasomes’ involvement in the pathogenesis of oral diseases (mainly periodontitis) and general pathologies, including approaches to control inflammasome-related pathogenic mechanisms. The inflammasomes are part of the innate immune response that activates inflammatory caspases by canonical and noncanonical pathways, to control the activity of Gasdermin D. Once an inflammasome is activated, pro-inflammatory cytokines, such as interleukins, are released. Thus, inflammasomes are involved in inflammatory, autoimmune and autoinflammatory diseases. The review also investigated novel therapies based on the use of phytochemicals and pharmaceutical substances for inhibiting inflammasome activity. Pharmaceutical substances can control the inflammasomes by three mechanisms: inhibiting the intracellular signaling pathways (Allopurinol and SS-31), blocking inflammasome components (VX-765, Emricasan and VX-740), and inhibiting cytokines mediated by the inflammasomes (Canakinumab, Anakinra and Rilonacept). Moreover, phytochemicals inhibit the inflammasomes by neutralizing reactive oxygen species. Biomaterials functionalized by the adsorption of therapeutic agents onto different nanomaterials could represent future research directions to facilitate multimodal and sequential treatment in oral pathologies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Kawasaki Disease and Coronary Complications · Cholesterol and Lipid Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oral Rehabilitation, Faculty of Dentistry, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania

Department of Chemistry and Chemical Engineering of Hungarian Line of Study, Faculty of Chemistry and Chemical Engineering, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania

Department of Histology, Faculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania

Department of Paediatric, Faculty of Dentistry, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca 400012, Romania

Department of Orthodontics, Faculty of Dentistry, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca 400012, Romania

Funding

Ministry of Research, Innovation and Digitization, CNCS—UEFISCDI

References (100+)

Show source-provided references
1. Polymicrobial communities in periodontal disease: Their quasi-organismal nature and dialogue with the host10.1111/prd.12371 ↗
2. Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity10.1016/j.cell.2021.05.013 ↗
3. The oral microbiota: Dynamic communities and host interactions10.1038/s41579-018-0089-x ↗
4. Complement is required for microbe-driven induction of Th17 and periodontitis10.4049/jimmunol.2200338 ↗
5. Neutrophils at work10.1038/ni.2921 ↗
6. How has neutrophil research improved our understanding of periodontal pathogenesis?10.1111/j.1600-051X.2010.01678.x ↗
7. Periodontal Pathogens’ strategies disarm neutrophils to promote dysregulated inflammation10.1111/omi.12321 ↗
8. Granulopoiesis and granules of human neutrophils10.1111/imr.12440 ↗
9. Biological roles of neutrophil-derived granule proteins and cytokines10.1016/j.it.2019.05.003 ↗
10. Miralda, I., Uriarte, S.M., and McLeish, K.R. (2017). Multiple phenotypic changes define neutrophil priming. Front. Cell Infect. Microbiol., 7.10.3389/fcimb.2017.00217 ↗
11. The roles of neutrophils linking periodontitis and atherosclerotic cardiovascular diseases10.3389/fimmu.2022.915081 ↗
12. Defective priming of the phagocyte oxidative burst in a child with recurrent intracellular infections10.1016/S1286-4579(99)80057-4 ↗
13. A common genetic variant in TLR1 enhances human neutrophil priming and impacts length of intensive care stay in pediatric sepsis10.4049/jimmunol.1500856 ↗
14. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis10.1111/j.1365-2249.2006.03276.x ↗
15. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis10.1136/ard.54.11.916 ↗
16. Trained immunity, tolerance, priming and differentiation: Distinct immunological processes10.1038/s41590-020-00845-6 ↗
17. Porphyromonas gingivalis: Immune subversion activities and role in periodontal dysbiosis10.1007/s40496-020-00249-3 ↗
18. The role of TLRs in neutrophil activation10.1016/j.coph.2011.06.007 ↗
19. Complementdependent mechanisms and interventions in periodontal disease10.3389/fimmu.2019.00406 ↗
20. Novel mechanisms and functions of complement10.1038/ni.3858 ↗
21. Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll-like receptor 2, and phosphatidylinositol-3-kinase10.1002/eji.200425883 ↗
22. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: Structure, function and assembly of multidomain protein complexes10.2174/1389203033487036 ↗
23. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss10.4049/jimmunol.1003252 ↗
24. ygiW and qseBC are co-expressed in Aggregatibacter actinomycetemcomitans and regulate biofilm growth10.1099/mic.0.066183-0 ↗
25. Aggregatibacter actinomycetemcomitans QseBC is activated by catecholamines and iron and regulates genes encoding proteins associated with anaerobic respiration and metabolism10.1111/omi.12101 ↗
26. The hunger games: Aggregatibacter actinomycetemcomitans exploits human neutrophils as an epinephrine source for survival10.3389/fimmu.2021.707096 ↗
27. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-1710.1016/j.immuni.2005.01.011 ↗
28. Cholesterol, inflammation and innate immunity10.1038/nri3793 ↗
29. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis10.1161/CIRCULATIONAHA.110.961714 ↗
30. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis10.1016/j.cmet.2013.04.001 ↗
31. Complement: A key system for immune surveillance and homeostasis10.1038/ni.1923 ↗
32. Safety and efficacy of the complement inhibitor AMY-101 in a natural model of periodontitis in non-human primates10.1016/j.omtm.2017.08.001 ↗
33. Dahlen, G., Basic, A., and Bylund, J. (2019). Importance of Virulence Factors for the Persistence of Oral Bacteria in the Inflamed Gingival Crevice and in the Pathogenesis of Periodontal Disease. J. Clin. Med., 8.10.3390/jcm8091339 ↗
34. Great Balls of Fire: Activation and Signalling of Inflammatory Caspases10.1042/BST20200986 ↗
35. Expression and regulation of the NALP3 inflammasome complex in periodontal diseases10.1111/j.1365-2249.2009.03972.x ↗
36. Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics10.1111/prd.12269 ↗
37. Cutting edge: CATERPILLER: A large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains10.4049/jimmunol.169.8.4088 ↗
38. The NLR gene family: A standard nomenclature10.1016/j.immuni.2008.02.005 ↗
39. Harijith, A., Ebenezer, D., and Natarajan, V. (2014). Reactive oxygen species at the crossroads of inflammasome and inflammation. Front. Physiol., 5.10.3389/fphys.2014.00352 ↗
40. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin10.1038/ng1724 ↗
41. ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis10.1111/j.1462-5822.2009.01390.x ↗
42. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes10.1016/j.cyto.2012.03.016 ↗
43. Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions10.1016/j.micinf.2007.01.018 ↗
44. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome10.4049/jimmunol.0802696 ↗
45. Regulation of inflammasome signaling10.1038/ni.2237 ↗
46. Nlrp6 regulates intestinal antiviral innate immunity10.1126/science.aab3145 ↗
47. ATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptides10.1016/j.molimm.2015.06.013 ↗
48. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals10.1074/jbc.M502820200 ↗
49. Sensing bacterial infections by NAIP receptors in NLRC4 inflammasome activation10.1007/s13238-012-2028-3 ↗
50. Cutting edge: NLRC5- dependent activation of the inflammasome10.4049/jimmunol.1003111 ↗
51. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes10.1007/s10875-010-9425-2 ↗
52. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA10.1038/nature07710 ↗
53. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases10.1042/BSR20120055 ↗
54. Pathogen Recognition by the Innate Immune System10.3109/08830185.2010.529976 ↗
55. Sordi, M.B., de Souza Magini, R., Panahipour, L., and Gruber, R. (2022). Pyroptosis-Mediated Periodontal Disease. Int. J. Mol. Sci., 23.10.3390/ijms23010372 ↗
56. Cotranu, I., and Mareş, L. (2009). Explanatory Dictionary of the Romanian Language, Encyclopedic Universe Gold. [2nd ed.].
57. A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers10.1111/cts.13607 ↗
58. Ferroptosis: Death by Lipid Peroxidation10.1016/j.tcb.2015.10.014 ↗
59. NETosis: Molecular Mechanisms, Role in Physiology and Pathology
60. Caspase-1-Induced Pyroptosis Is an Innate Immune Effector Mechanism against Intracellular Bacteria10.1038/ni.1960 ↗
61. Shigella flexneri Induces Apoptosis in Infected Macrophages10.1038/358167a0 ↗
62. Pro-Inflammatory Programmed Cell Death10.1016/S0966-842X(00)01936-3 ↗
63. The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification10.1007/s10753-020-01357-z ↗
64. Pyroptosis Is Driven by Non-Selective Gasdermin-D Pore and Its Morphology Is Different from MLKL Channel-Mediated Necroptosis10.1038/cr.2016.100 ↗
65. Inflammasomes and Their Roles in Health and Disease10.1146/annurev-cellbio-101011-155745 ↗
66. NLRP6 Induces Pyroptosis by Activation of Caspase-1 in Gingival Fibroblasts10.1177/0022034518775036 ↗
67. A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-induced Activation of the Nlrp3 Inflammasome10.4049/jimmunol.0900729 ↗
68. K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter10.1016/j.immuni.2013.05.016 ↗
69. Biological Applications of Ionophores10.1146/annurev.bi.45.070176.002441 ↗
70. Up-Regulation of the Endoplasmic Reticulum Stress-Response in Periodontal Disease10.1016/j.cca.2008.12.007 ↗
71. Hörauf, J.-A., Kany, S., Janicova, A., Xu, B., Vrdoljak, T., Sturm, R., Dunay, I.R., Martin, L., and Relja, B. (2020). Short Exposure to Ethanol Diminishes Caspase-1 and ASC Activation in Human HepG2 Cells in Vitro. Int. J. Mol. Sci., 21.10.3390/ijms21093196 ↗
72. Pyroptosis: Host Cell Death and Inflammation10.1038/nrmicro2070 ↗
73. Methodology for Comprehensive Detection of Pyroptosis10.1007/978-1-0716-1162-3_13 ↗
74. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction10.1902/jop.2003.74.3.391 ↗
75. The inflammasome NLRs in immunity, inflammation, and associated diseases10.1146/annurev-immunol-031210-101405 ↗
76. Historical aspects of studies on roles of the inflammasome in the pathogenesis of periodontal diseases10.1111/omi.12217 ↗
77. The inflammasomes10.1016/j.cell.2010.01.040 ↗
78. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta10.1016/S1097-2765(02)00599-3 ↗
79. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation10.1038/s41586-018-0372-z ↗
80. The Expression of NLRP3, NLRP1 and AIM2 in the Gingival Tissue of Periodontitis Patients: RT-PCR Study and Immunohistochemistry10.1016/j.archoralbio.2015.03.005 ↗
81. Porphyromonas gingivalis Lipopolysaccharide Affects Oral Epithelial Connections via Pyroptosis10.1016/j.jds.2021.01.003 ↗
82. Functional role of interleukin 1 in periodontal disease: Induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice10.1128/iai.50.1.262-270.1985 ↗
83. Localization of interleukin-1 beta in human periodontal tissue10.1902/jop.1991.62.1.36 ↗
84. Bioassay of interleukin 1 (IL-1) in human gingival crevicular fluid during experimental gingivitis10.1016/0003-9969(92)90011-V ↗
85. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis10.4049/jimmunol.160.1.403 ↗
86. Regulation of NLRP3 and AIM2 inflammasome gene expression levels in gingival fibroblasts by oral biofilms10.1016/j.cellimm.2011.04.002 ↗
87. CD24 activates the NLRP3 inflammasome through c-Src kinase activity in a model of the lining epithelium of inflamed periodontal tissues10.1002/iid3.40 ↗
88. Yamaguchi, Y., Kurita-Ochiai, T., Kobayashi, R., Suzuki, T., and Ando, T. (2015). Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis. Pathog. Dis., 73.10.1093/femspd/ftv011 ↗
89. Structures and Functions of the Inflammasome Engine10.1016/j.jaci.2021.04.018 ↗
90. Inflammasome as a Key Pathogenic Mechanism in Endometriosis10.2174/1389450117666160709013850 ↗
91. Hyperglucose contributes to periodontitis: Involvement of the NLRP3 pathway by engaging the innate immunity of oral gingival epithelium10.1902/jop.2014.140403 ↗
92. Noncanonical inflammasome activation targets caspase-1110.1038/nature10558 ↗
93. Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation10.1016/j.cell.2017.09.029 ↗
94. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis10.1126/science.aaa8064 ↗
95. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation10.1182/blood-2013-05-504449 ↗
96. Segovia, J., Sabbah, A., Mgbemena, V., Tsai, S.Y., Chang, T.H., and Berton, M.T. (2012). TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE, 7.10.1371/journal.pone.0029695 ↗
97. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis10.1002/eji.201141548 ↗
98. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity10.1002/eji.200838549 ↗
99. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling10.1038/ni.2022 ↗
100. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD10.1681/ASN.2010020143 ↗